Citi lowered the firm’s price target on DexCom (DXCM) to $85 from $105 and keeps a Buy rating on the shares. The firm is cautious on medical ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them. DexCom ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of its brand ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

Social Security beneficiaries could see a 2.7% cost-of-living adjustment (COLA) next year, which is slightly more than the 2.5% boost U.S. retirees received this year. The new estimate comes from the ...

The UK is set to face one of the highest inflation rates of any major economy in the world in a significant cost of living blow to Britons. The Organisation of Economic Co-operation and Development ...

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...

The EU will delay the formal proposal of its 19th package of sanctions against Russia as it seeks to coordinate more closely the actions with planned G7 measures, an EU diplomat told Bloomberg on ...

DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose biosensing technology for ...

The company is presenting several abstracts during the five-day conference showcasing clinical and real-world evidence that support the benefits of its products. Dexcom is presenting several abstracts ...